Glycodiagnostics

Aberrant protein glycosylation is well known hallmark of cancer and represents a promising source of potential new biomarkers.  At Glycodots we actively working on novel rapid diagnostics for the detection of breast, liver and pancreatic cancers using novel glycobiomarkers that are exceptionally specific.